NYSE:CLB - Core Laboratories Stock Price, Forecast & News

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Core Laboratories announced a quarterly dividend on Wednesday, January 15th. Investors of record on Friday, January 24th will be given a dividend of $0.25 per share on Friday, February 14th. This represents a $1.00 dividend on an annualized basis and a yield of 2.57%. The ex-dividend date of this dividend is Thursday, January 23rd. View Core Laboratories' Dividend History.

Core Laboratories (NYSE:CLB) released its quarterly earnings results on Wednesday, October, 23rd. The oil and gas company reported $0.50 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.49 by $0.01. The oil and gas company had revenue of $173.20 million for the quarter, compared to analyst estimates of $171.38 million. Core Laboratories had a net margin of 14.68% and a return on equity of 45.63%. The business's quarterly revenue was down 4.9% compared to the same quarter last year. During the same period in the prior year, the company posted $0.64 earnings per share. View Core Laboratories' Earnings History.

Core Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, January 29th 2020. View Earnings Estimates for Core Laboratories.

Core Laboratories will be holding an earnings conference call on Wednesday, January 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Core Laboratories issued an update on its first quarter earnings guidance on Tuesday, December, 31st. The company provided earnings per share (EPS) guidance of $0.39-0.41 for the period, compared to the Thomson Reuters consensus estimate of $0.45. The company issued revenue guidance of $159-164 million, compared to the consensus revenue estimate of $163.39 million.

13 Wall Street analysts have issued 1-year target prices for Core Laboratories' shares. Their forecasts range from $38.80 to $77.00. On average, they expect Core Laboratories' stock price to reach $50.33 in the next twelve months. This suggests a possible upside of 29.2% from the stock's current price. View Analyst Price Targets for Core Laboratories.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 10 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Core Laboratories.

Media stories about CLB stock have trended somewhat positive on Wednesday, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Core Laboratories earned a news impact score of 2.0 on InfoTrie's scale. They also assigned media stories about the oil and gas company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Core Laboratories.

Core Laboratories saw a drop in short interest in the month of December. As of December 31st, there was short interest totalling 2,830,000 shares, a drop of 8.4% from the December 15th total of 3,090,000 shares. Based on an average trading volume of 713,800 shares, the short-interest ratio is currently 4.0 days. Approximately 6.5% of the shares of the company are sold short. View Core Laboratories' Current Options Chain.

Some companies that are related to Core Laboratories include Subsea 7 (SUBCY), Oceaneering International (OII), Helix Energy Solutions Group (HLX), NexTier Oilfield Solutions (NEX), SemGroup (SEMG), Liberty Oilfield Services (LBRT), Propetro (PUMP), RPC (RES), Select Energy Services (WTTR), Franks International (FI), National Energy Services Reunited (NESR), Keane Group (FRAC), Hurricane Energy (HRCXF), North American Construction Group (NOA) and Natural Gas Services Group (NGS).

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Chipotle Mexican Grill (CMG), Starbucks (SBUX), Micron Technology (MU), AT&T (T), Baidu (BIDU), NIC (EGOV) and Netflix (NFLX).

Core Laboratories' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Manning & Napier Group LLC (1.57%), Scout Investments Inc. (0.17%), Viking Fund Management LLC (0.14%), Kopion Asset Management LLC (0.08%), Alpine Global Management LLC (0.05%) and Ridgewood Investments LLC (0.03%). Company insiders that own Core Laboratories stock include Gregory Barry Barnett, Jan Willem Sodderland, Kevin Daniels and Mark F Elvig. View Institutional Ownership Trends for Core Laboratories.

CLB stock was sold by a variety of institutional investors in the last quarter, including Manning & Napier Group LLC, Farmers & Merchants Investments Inc., Scout Investments Inc. and State of Alaska Department of Revenue. Company insiders that have sold Core Laboratories company stock in the last year include Kevin Daniels and Mark F Elvig. View Insider Buying and Selling for Core Laboratories.

CLB stock was acquired by a variety of institutional investors in the last quarter, including Kopion Asset Management LLC, Alpine Global Management LLC, Viking Fund Management LLC, OLD National Bancorp IN, Zurcher Kantonalbank Zurich Cantonalbank and Ridgewood Investments LLC. Company insiders that have bought Core Laboratories stock in the last two years include Gregory Barry Barnett and Jan Willem Sodderland. View Insider Buying and Selling for Core Laboratories.

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CLB stock can currently be purchased for approximately $38.96.

Core Laboratories has a market capitalization of $1.73 billion and generates $700.85 million in revenue each year. The oil and gas company earns $79.52 million in net income (profit) each year or $2.28 on an earnings per share basis. Core Laboratories employs 4,700 workers across the globe.View Additional Information About Core Laboratories.

The official website for Core Laboratories is http://www.corelab.com/.

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]